AB-16

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameAB-16
Drug Alias NameAB-16
ClassificationSmall molecules > Autophagy-Targeting Chimeras (AUTOTAC)
Mechanisms of ActionSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAutotac Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAutotac Bio Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A